Therapeutic efficacy of anti-malarials in Plasmodium falciparum malaria in an Indo-Myanmar border area of Arunachal Pradesh

Indian Journal of Medical Research

Volumn 118, Issue AUG., 2003, Pages 71-76

  Mohapatra, P K ^a   Namchoom, N S ^b   Prakash, Anil ^a   Bhattacharya, D R ^a   Goswami, B K ^a   Mahanta, J ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE   (India)

^b Primary Health Centre   (India)

Author keywords

Chloroquine; Falciparum malaria; In vivo resistance; Indo Myanmar border; North East India; Sulfadoxine+pyrimethamine; Therapeutic failure

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR; MEFLOQUINE; QUININE;

ADOLESCENT; ADULT; ARTICLE; BRAIN MALARIA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; FOLLOW UP; GASTRITIS; HOSPITAL; HUMAN; IN VIVO STUDY; INDIA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MYANMAR; NAUSEA AND VOMITING; PARASITEMIA; PARASITOLOGY; PLASMODIUM FALCIPARUM; TINNITUS; TREATMENT FAILURE; VERTIGO;

ADOLESCENT; ADULT; ANTIMALARIALS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INDIA; MALARIA, FALCIPARUM; MALE; MYANMAR; TREATMENT OUTCOME;

EID: 0345170979     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bloland PB. Drug Resistance in Malaria. Geneva: World Health Organizaton 2001. WHO/CDS/CSR/DRS/2001.4.
2. World Health Organization. The Use of Antimalarial Drugs. Report of a WHO Informal Consultation (13-17 Nov. 2000). Roll Back Malaria. WHO, Geneva; 2001. WHO/CDS/RBM/2001.33.
3. Wernsdorfer WH, Payne D. The dynamics of drug resistance in Plasmodium falciparum. Pharmac Ther 1991; 50 : 95-121.
4. Sehgal PN, Sharma MID, Sharma SL, Gogai S. Resistance to chloroquine in falciparum malaria in Assam state, India. J Commun Dis 1975; 5 : 175-80.
5. Shivlal, Dhillon GPS, Sonal GS, Arora U, Nandi J, editors. Drug Resistance and Chemotherapy of Malaria in India, an Update 1997. Delhi: National Malaria Eradication Programme (Enhanced Malaria Control Project), Ministry of Health and Family Welfare. Government of India, 1997.
6. Barkakaty BN, Narasimham MVVL. Efficacy of a low dose of oral quinine therapy in Plasmodium falciparum cases of Assam, Meghalaya and Arunachal Pradesh in India. J Commun Dis 1991; 23 : 248-53.
7. Ejov MN, Tun T, Aung S, Sein K. Response of falciparum malaria to different antimalarias in Myanmar. Bull World Health Organ 1999; 77 : 244-9.
8. Operational Manual for Malaria Action Programme (MAP). Delhi: National Malaria Eradication Programme, Ministry of Health and Family Welfare, Government of India, 1995.
9. Mohapatra PK, Prakash A, Bhattacharya DR, Goswani BK, Mahanta J. Concurrent multidrug resistant Plasmodium falciparum from northeast India. J Assoc Physicians India 1999; 47 : 823-4.
10. Mohapatra PK, Narain K, Prakash A, Bhattacharya DR, Mahanta J. Risk factors of malaria in the fringes of an evergreen monsoon forest of Arunachal Pradesh. Natl Med J India 2001; 14 : 139-42.
11. Severe falciparum malaria : World Health Organisation. Communicable disease clusters. Trans R Soc Trop Med Hyg 2000; 94 : Supplement 1 : s1-90.
12. World Health Organisation. Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission; 1996. WHO/MAL/96.1077.
13. Clyde DF. Variations in response of malaria parasite to drugs in Asia and Oceania. La Med Trop 1987; 3 : 3-22.
14. Verdrager J. Epidemiology of emergence and spread of drug resistant falciparum malaria in South-east Asia. Southeast Asian J Trop Med Public Health 1986; 17 : 111-8.
15. World Health Organisation. Antimalarial Drug Combination Therapy. Report of a WHO Technical Consultation (4-5 April, 2001). Roll Back Malaria. WHO, Geneva; 2001. WHO/CDS/RBM/2001.35.